84 research outputs found

    Empowering Rural Sociology: Exploring and Linking Alternative Paradigms in Theory and Methodology

    Get PDF
    An article written in part by Suzanne E. Tallichet and published in the 1995 issue of Rural Sociology, pages 585-606

    Women Farmers: Pulling Up Their Own Educational Boot Straps with Extension

    Get PDF
    Women comprise a rapidly growing segment in agriculture. In this article, we examine how a network of women farmers, Extension educators, and researchers responded to the significant increase in women farmers in one state by creating a membership organization that draws on the expertise and resources of the land-grant university and Extension in Pennsylvania to create educational events with networking opportunities. We report 4 years of evaluation data for 37 events indicating educational impact, expansion and enhancement of the network, and marketing strategies for Extension to improve participation of women

    The health of women and girls determines the health and well-being of our modern world: A White Paper From the International Council on Women's Health Issues

    Get PDF
    The International Council on Women's Health Issues (ICOWHI) is an international nonprofit association dedicated to the goal of promoting health, health care, and well-being of women and girls throughout the world through participation, empowerment, advocacy, education, and research. We are a multidisciplinary network of women's health providers, planners, and advocates from all over the globe. We constitute an international professional and lay network of those committed to improving women and girl's health and quality of life. This document provides a description of our organization mission, vision, and commitment to improving the health and well-being of women and girls globally

    Safety and Reactogenicity of an MSP-1 Malaria Vaccine Candidate: A Randomized Phase Ib Dose-Escalation Trial in Kenyan Children

    Get PDF
    OBJECTIVE: Our aim was to evaluate the safety, reactogenicity, and immunogenicity of an investigational malaria vaccine. DESIGN: This was an age-stratified phase Ib, double-blind, randomized, controlled, dose-escalation trial. Children were recruited into one of three cohorts (dosage groups) and randomized in 2:1 fashion to receive either the test product or a comparator. SETTING: The study was conducted in a rural population in Kombewa Division, western Kenya. PARTICIPANTS: Subjects were 135 children, aged 12–47 mo. INTERVENTIONS: Subjects received 10, 25, or 50 μg of falciparum malaria protein 1 (FMP1) formulated in 100, 250, and 500 μL, respectively, of AS02A, or they received a comparator (Imovax® rabies vaccine). OUTCOME MEASURES: We performed safety and reactogenicity parameters and assessment of adverse events during solicited (7 d) and unsolicited (30 d) periods after each vaccination. Serious adverse events were monitored for 6 mo after the last vaccination. RESULTS: Both vaccines were safe and well tolerated. FMP1/AS02A recipients experienced significantly more pain and injection-site swelling with a dose-effect relationship. Systemic reactogenicity was low at all dose levels. Hemoglobin levels remained stable and similar across arms. Baseline geometric mean titers were comparable in all groups. Anti-FMP1 antibody titers increased in a dose-dependent manner in subjects receiving FMP1/AS02A; no increase in anti-FMP1 titers occurred in subjects who received the comparator. By study end, subjects who received either 25 or 50 μg of FMP1 had similar antibody levels, which remained significantly higher than that of those who received the comparator or 10 μg of FMP1. A longitudinal mixed effects model showed a statistically significant effect of dosage level on immune response (F(3,1047) = 10.78, or F(3, 995) = 11.22, p < 0.001); however, the comparison of 25 μg and 50 μg recipients indicated no significant difference (F(1,1047) = 0.05; p = 0.82). CONCLUSIONS: The FMP1/AS02A vaccine was safe and immunogenic in malaria-exposed 12- to 47-mo-old children and the magnitude of immune response of the 25 and 50 μg doses was superior to that of the 10 μg dose

    Publish or perish? Don't perish!

    No full text
    Presented by Ann Tickamyer and Carolyn Sachs (Pennsylvania State University), as part of the Annual Gender Capacity Development Workshop hosted by the CGIAR Collaborative Platform for Gender Research, Addis Ababa, 27-28 September 2018

    Feminist food sovereignty

    No full text
    • …
    corecore